Role of granulocytes in endothelial injury in coronary heart disease in humans

Atherosclerosis

Volumn 91, Issue 1-2, 1991, Pages 1-14

  Ricevuti, Giovanni ^a   Mazzone1, Antonino ^a   Pasotti, Davide ^a   Servi, Stefano de ^b   Specchia, Giuseppe ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Coronary artery disease; Granulocytes; Leukotrienes

Indexed keywords

LEUKOTRIENE A4; LEUKOTRIENE C4;

CORONARY REPERFUSION; HEART INFARCTION; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMAL; CELL AGGREGATION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMAN; MYOCARDIUM; NEUTROPHILS; SRS-A;

EID: 0025940393     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(91)90182-3     Document Type: Review

References (86)

1. Neutrophils in human disease
2. Tissue destruction by neutrophils
3. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage
4. Role of hydrogen peroxide in neutrophilmediated destruction of cultured endothelial cells
5. Complement and leukocyte-mediated pulmonary dysfunctiod in hemodialysis
6. The neutrophils revisited
7. Neutrophil function in ischemic heart disease
8. Leukocytes and leukocyte-derived products in myocardial ischemic injury
9. Neutrophils as potential participants in acute myocardial ischemia: relevance to perfusion
10. The leukocyte count as a predictor of myocardial infarction
11. Leukocyte count, smoking and myocardial infarction
12. Leukocytes and the risk of ischemic heart disease
13. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography
14. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
15. Leukocyte counts and activation in spontaneously hypertensive rats
16. 2 on coronary flow and myocardial function
17. Neutrophils function in coronary artery disease
18. Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs
19. Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion
20. Oxygen-derived free radicals and stunned myocardium
21. Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers
22. Effects of leukocyte activation on myocardial vascular resistance
23. Oxygen radicals in the adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage
24. Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion
25. Endothelial and myocardial injury during ischemia and reperfusion, pathogenesis and therapeutic implications
26. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog
27. Role of neutrophils in ischemic heart disease, pathophysiologic role in myocardial ischemia and coronary artery reperfusion
28. Leucocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury
29. Granulocyte aggregation after coronary angioplasty in human
30. Release of inflammatory mediators from stimulated neutrophils
31. Platelet-derived growth factor promotes polymorphonuclear leukocyte activation
32. Preparation and characterization of monoclonal antibodies to human neutrophil cathepsin G, lactoferrin, eosinophil peroxidase, and eosinophil major basic protein
33. Characterization of gelatinase from pig polymorphonuclear leukocytes. A metalloproteinase resembling tumor type IV collagenase
34. The production of tumor necrosis factor, tissue thromboplastin, lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood
35. Granulocyte aggregation as a manifestation of membrane interactions with complement, possible role in leukocyte margination, microvascular occlusion and endothelial damage
36. Tissue injury in inflammation, oxidants, proteinases and cationic proteins
37. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion
38. Lipid peroxidation and endothelial cell injury, implications in atherosclerosis
39. 2 production, adenine nucleotide release, and response to vasoactive agents
40. Soluble human complement receptor type ],In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
41. Temporal changes in 12-HETE formation in two models of canine myocardial infarction
42. Release of leukotriene C4 from human polymorphonuclear leukocytes as determined by radioimmunoassay
43. Prostaglandins, thromboxanes, and leukotrienes, formation and biological roles
44. The biologically active leukotrienes
45. Leukotrienes in health and disease
46. 4 in the intact pig heart
47. Leukotrienes, mediators of immediate hypersensitivity reactions and inflammation
48. Cardiovascular and metabolic effects of peptide leukotrienes in man
49. 4 synthesized by polymorphonuclear leukocytes
50. Cooperative synthesis of leukotrienes by leukocytes and vascular cells
51. Coronary vasoconstriction and PG12 release by leukotrienes in isolated guinea pig hearts
52. Metabolism and analysis of endogenous cysteinyl leukotrienes
53. Leukotriene biosynthesis by canine and human coronary arteries
54. Leukotriene production by human vascular tissues, possible link between the nature of the atherosclerosic lesions and their clinical activity
55. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor
56. Activation of the terminal complement pathway in atherosclerosis
57. Purification and amino acid sequencing of NAF a novel neutrophil-activating factor produced by monocytes
58. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity
59. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines
60. A novel neutrophil-activating factor produced by human mononuclear phagocyte
61. Leukocyte adherence in arterioles following extravascular tissue trauma
62. Endothelial leukocyte adhesion molecule 1: an inducibile receptor for neutrophils related to complement regulatory proteins and lectins
63. Factors influencing leukocyte adherence in microvessels
64. Neutrophil adherence receptors (CD18) in ischemia
65. The endothelium-modulator of vascular smooth-muscle tone
66. Complement induced granulocyte aggregation in vivo
67. Complement (C5a)—induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia
68. Neutrophil aggregation: present and perspective in medical pathology
69. Human endothelial cells inhibit granulocyte aggregation in vitro
70. Complement-induced granulocyte aggregation. An unsuspected mechanism of disease
71. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products
72. The leukergy test in patients with ischemic heart disease
73. Activation of arachidonic acid metabolism during aggregation of polymorphonuclear granulocytes
74. Cholesterol and atheroma lipids actvate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states
75. Leukocyte-endothelial interactions
76. Neutrophil adherence to isolated canine myocytes
77. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombinstimulated endothelial cells
78. New trends in coronary artery disease, the role of granulocyte activation
79. Granulocytes and myocardial ischemia
80. Increased neutrophil aggregability in coronary artery disease
81. Pharmacologic aspects of cigarette smoking and nicotine addiction
82. Consequence of leukocyte-vessel wall interactions in inflammatory and immune reactions
83. Interaction between morphine and granulocyte aggregation in myocardial ischemia
84. 4 from granulocytes
85. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation of human neutrophil/platelet mixtures
86. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia